HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the United States Patent and Trademark Office has issued two U.S. Patents covering HTG’s technology and applications of its technology.
“The newly issued patents substantiate the proprietary nature of our business and represent an important step in protecting our technology and its applications,” stated TJ Johnson, Chief Executive Officer of HTG. “As we grow, we will continue to pursue additional protection around our instrument portfolio and our testing methods and their applications in the U.S. and in other regions and countries.”
Read full article here